Beovu & Recarbrio Among Five Drugs On Track For EU-Wide Approval
No Decision On Celgene/Agios Pharmaceuticals’ AML Drug Enasidenib
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
You may also be interested in...
The number of positive opinions given by the EMA’s CHMP has fallen to 66 this year from 84 in 2018.
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.
Medical products that do not fully comply with Canadian requirements but are manufactured according to comparable standards are being allowed into the country to deal with COVID-19-related shortages.